NovoCure
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.About NVCR
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.
NVCR Key Statistics
Stock Snapshot
As of today, NovoCure(NVCR) shares are valued at $16.04. The company's market cap stands at 1.83B, with a P/E ratio of -12.44.
On 2026-05-01, NovoCure(NVCR) stock moved within a range of $15.12 to $16.54. With shares now at $16.04, the stock is trading +6.1% above its intraday low and -3.0% below the session's peak.
Trading volume for NovoCure(NVCR) stock has reached 1.04M, versus its average volume of 1.74M.
The stock's 52-week range extends from a low of $9.82 to a high of $20.06.
The stock's 52-week range extends from a low of $9.82 to a high of $20.06.
NVCR News
Image source: The Motley Fool. Thursday, Apr. 30, 2026 at 8 a.m. ET Call participants Executive Chairman — William Doyle Chief Executive Officer — Frank Leonar...
NovoCure (NVCR) shares surged nearly 22% on Thursday after the oncology company posted first-quarter revenue well above Wall Street estimates and raised its ann...
Reports 1Q revenue $174.055M, consensus $167.77M. “This was a very strong start to the year for Novocure (NVCR) and we are pleased with the progress made across...
Analyst ratings
75%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.